Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 9.59
+0.71 (8.00%)
Jul 16, 2025, 1:58 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 3.75 billion as of July 16, 2025. Its market cap has decreased by -45.42% in one year.
Market Cap
3.75B
Enterprise Value
3.56B
Revenue
4.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.59
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has decreased from 5.10B to 3.75B, a decrease of -26.60%. That is a compound annual growth rate of -11.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 3.75B | -31.87% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 188.45B |
| PharmaEssentia | 175.63B |
| Bora Pharmaceuticals Co., LTD. | 84.20B |
| Lotus Pharmaceutical | 55.88B |
| Oneness Biotech | 29.13B |
| Polaris Group | 29.05B |
| Center Laboratories | 26.46B |
| Lumosa Therapeutics | 23.13B |